Downloads
Article: Norway's Growing Biopharma Industry
By Suzanne Elvidge
Norway has a growing pharmaceutical industry with strengths in therapeutics and diagnostics in a number of key areas, including cancer and neurosciences. With its strong history in the biomedical sciences, this makes it an attractive location for companies that want to establish a base or set up a collaboration in Norway.
"The Norwegian biopharma industry is emerging and has ambitions to become a significant international entity, though it is not yet very well known outside Scandinavia," says Bo I. Nilsson, M.D., Ph.D., Chief Medical Officer, Clavis Pharma. Clavis Pharma is an oncology-focused pharmaceutical company based in Oslo, with a number of anticancer therapeutics in clinical development.
Used with permission from Life Science Leader magazine.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get access to this piece of content and thousands of additional articles and product reviews across our entire network of sites.
